Rare diseases
Investigational molecules
Locations
345 conditions with trials, the busiest first
956 trials across Europe, recruiting first
Study of Azenosertib and Niraparib for Patients with Platinum-Resistant Ovarian Cancer
FranceStudy on Avelumab for Patients with Advanced or Metastatic Squamous Cell Penile Cancer After Initial Chemotherapy
FranceStudy Comparing Oil-Based and Water-Based Contrast Media for Infertility in Women: Iodixanol and Ethyl Esters of Iodised Fatty Acids from Poppyseed Oil
The NetherlandsStudy on the Effects of XP-DC+TL+KLH in Patients with Ovarian Cancer Undergoing Chemotherapy
The NetherlandsStudy of PF-06821497 with Enzalutamide for Men with Metastatic Castration-Resistant Prostate Cancer Previously Treated with Abiraterone Acetate
CzechiaStudy on Testosterone Therapy for Men with Low Testosterone and Prostate Cancer Undergoing Surgery
The NetherlandsStudy comparing carboplatin-cyclophosphamide versus paclitaxel with atezolizumab as first treatment for advanced triple negative breast cancer
The NetherlandsStudy on Avelumab for Patients with High-Risk Triple Negative Breast Cancer
ItalyStudy on Electrochemotherapy with Bleomycin and Cisplatin for Treating Vulvar Paget's Disease and Precancerous Lesions in Newly Diagnosed or Recurrent Patients
ItalyStudy on Doxorubicin Hydrochloride and Trabectedin for Patients with Recurrent Ovarian Cancer
ItalyStudy on Treating Metastatic Castration-Resistant Prostate Cancer with 177Lu-PNT2002 Compared to Abiraterone or Enzalutamide for Patients After Hormonal Therapy
FranceStudy on Abemaciclib, Letrozole, and Fulvestrant for Patients with Advanced HR-positive/HER2-negative Breast Cancer
ItalyThe therapies tested most often in Reproductive system and breast disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
